Dalpiciclib. Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, Treatment of HR+/HER2- and HER2+ advanced breast cancer
-
Published:2022
Issue:12
Volume:47
Page:867
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Wang J.,Dong X.,Ashby C.R.,Chen Z.-S.,Zhang Y.
Subject
Pharmacology (medical),Pharmacology